4.5 Article

Structure of the full-length Clostridium difficile toxin B

期刊

NATURE STRUCTURAL & MOLECULAR BIOLOGY
卷 26, 期 8, 页码 712-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41594-019-0268-0

关键词

-

资金

  1. National Institute of Health [R01AI139087, R01AI125704, R21AI123920, R21AI139690, R21CA235533, R01GM074830, R01GM130144, R01DK084509, R01AI088748, R01AI132207, U19AI109776, R01 MH081923]
  2. National Institute of General Medical Sciences [P30GM124165]
  3. NIH-ORIP HEI grant [S10 RR029205]
  4. U.S. DOE [DE-AC02-06CH11357]
  5. U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]
  6. DOE Office of Biological and Environmental Research
  7. National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]

向作者/读者索取更多资源

Clostridium difficile is an opportunistic pathogen that establishes in the colon when the gut microbiota are disrupted by antibiotics or disease. C. difficile infection (CDI) is largely caused by two virulence factors, TcdA and TcdB. Here, we report a 3.87-angstrom-resolution crystal structure of TcdB holotoxin that captures a unique conformation of TcdB at endosomal pH. Complementary biophysical studies suggest that the C-terminal combined repetitive oligopeptides (CROPs) domain of TcdB is dynamic and can sample open and closed conformations that may facilitate modulation of TcdB activity in response to environmental and cellular cues during intoxication. Furthermore, we report three crystal structures of TcdB-antibody complexes that reveal how antibodies could specifically inhibit the activities of individual TcdB domains. Our studies provide novel insight into the structure and function of TcdB holotoxin and identify intrinsic vulnerabilities that could be exploited to develop new therapeutics and vaccines for the treatment of CDI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Analytical

Characterization of In Vivo Protein Complexes via Chemical Cross-Linking and Mass Spectrometry

Yuefan Wang, Yingwei Hu, Naseruddin Hoti, Lan Huang, Hui Zhang

Summary: The study introduces a method to preserve protein complexes by in vivo cross-linking, followed by size exclusion chromatography and data-independent acquisition mass spectrometry, enabling the characterization of in vivo protein complexes from cells or tissues to determine their clinical importance. This approach can identify protein complexes not detected by the in vitro system, providing unique insights into protein functions.

ANALYTICAL CHEMISTRY (2022)

Article Chemistry, Analytical

Developing a Targeted Quantitative Strategy for Sulfoxide-Containing MS-Cleavable Cross-Linked Peptides to Probe Conformational Dynamics of Protein Complexes

Clinton Yu, Xiaorong Wang, Lan Huang

Summary: Cross-linking mass spectrometry has advanced significantly as a technology for studying protein-protein interactions and protein complex architectures. Targeted QXL-MS platforms, such as PRM-based approaches, allow for label-free comparative analysis of selected cross-links across multiple samples.

ANALYTICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Receptor binding mechanisms of Clostridioides difficile toxin B and implications for therapeutics development

Peng Chen, Rongsheng Jin

Summary: This article reviews recent research progress on the molecular mechanisms by which the Clostridioides difficile exotoxin TcdB recognizes Frizzed proteins (FZDs) and chondroitin sulfate proteoglycan 4 (CSPG4) as two major host receptors. The authors suggest that the receptor-binding sites and neutralizing epitopes on TcdB are ideal targets for the development of broad-spectrum inhibitors against various TcdB variants.

FEBS JOURNAL (2023)

Article Microbiology

Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies

Kwok-ho Lam, Jacqueline M. Tremblay, Kay Perry, Konstantin Ichtchenko, Charles B. Shoemaker, Rongsheng Jin

Summary: This study reports the identification and characterization of a large panel of new single-domain variable heavy-chain (VHH) antibodies that bind to the catalytic light chain (LC) of botulinum neurotoxins (BoNTs) and inhibit their protease activity. The researchers used a combination of X-ray crystallography and biochemical assays to investigate the structures and inhibition mechanisms of these VHHs, and found that they interact with the LC through diverse mechanisms and exhibit broad specificity. These findings are of great importance for the development of improved botulism therapeutics.

PLOS PATHOGENS (2022)

Article Multidisciplinary Sciences

Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition

Baohua Chen, Zheng Liu, Kay Perry, Rongsheng Jin

Summary: The study reveals the mechanism of how toxin A from Clostridioides difficile causes diarrhea by glucosylating and inactivating Rho and Ras family small GTPases, providing insights into substrate recognition.

SCIENTIFIC REPORTS (2022)

Correction Cell Biology

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer (vol 39, 110641, 2022)

Sohail Jahid, Jose A. Ortega, Linh M. Vuong, Isabella Maria Acquistapace, Stephanie J. Hachey, Jessica L. Flesher, Maria Antonietta La Serra, Nicoletta Brindani, Giuseppina La Sala, Jacopo Manigrasso, Jose M. Arencibia, Sine Mandrup Bertozzi, Maria Summa, Rosalia Bertorelli, Andrea Armirotti, Rongsheng Jin, Zheng Liu, Chi-Fen Chen, Robert Edwards, Christopher C. W. Hughes, Marco De Vivo, Anand K. Ganesan

CELL REPORTS (2022)

Article Cell Biology

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

Sohail Jahid, Jose A. Ortega, Linh M. Vuong, Isabella Maria Acquistapace, Stephanie J. Hachey, Jessica L. Flesher, Maria Antonietta La Serra, Nicoletta Brindani, Giuseppina La Sala, Jacopo Manigrasso, Jose M. Arencibia, Sine Mandrup Bertozzi, Maria Summa, Rosalia Bertorelli, Andrea Armirotti, Rongsheng Jin, Zheng Liu, Chi-Fen Chen, Robert Edwards, Christopher C. W. Hughes, Marco De Vivo, Anand K. Ganesan

Summary: CDC42 family GTPases control tumor cell invasion and angiogenesis, and a new drug called ARN22089 has been discovered to inhibit tumor growth and angiogenesis by modulating CDC42 signaling.

CELL REPORTS (2022)

Article Biology

Structure and conformational dynamics of Clostridioides difficile toxin A

Baohua Chen, Sujit Basak, Peng Chen, Changcheng Zhang, Kay Perry, Songhai Tian, Clinton Yu, Min Dong, Lan Huang, Mark E. Bowen, Rongsheng Jin

Summary: This study reports the crystal structure of Clostridioides difficile toxin A (TcdA), revealing its dynamic structure and pH-dependency. The study also identifies a small globular subdomain and the CROPs domain that protect the pore-forming region of TcdA at neutral pH. Furthermore, a rationally designed mutation drastically reduces the cytotoxicity of the toxin.

LIFE SCIENCE ALLIANCE (2022)

Article Biochemistry & Molecular Biology

Yeast Display Enables Identification of Covalent Single-Domain Antibodies against Botulinum Neurotoxin Light Chain A

Rafael Alcala-Torano, Mariha Islam, Jaclyn Cika, Kwok Ho Lam, Rongsheng Jin, Konstantin Ichtchenko, Charles B. Shoemaker, James A. Van Deventer

Summary: This study successfully utilized yeast display in combination with noncanonical amino acids to identify irreversible variants of single-domain antibodies that can bind to botulinum neurotoxin light chain A. Systematic evaluations revealed clones with retained binding function and site-dependent target specificity and crosslinking capabilities conferred by the noncanonical amino acids.

ACS CHEMICAL BIOLOGY (2022)

Article Chemistry, Analytical

Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry

Fenglong Jiao, Leah J. Salituro, Clinton Yu, Craig B. Gutierrez, Scott D. Rychnovsky, Lan Huang

Summary: The development of MS-cleavable cross-linking mass spectrometry (XL-MS) allows for the efficient capture and identification of endogenous protein-protein interactions (PPIs) without the need for cell engineering. However, existing lysine-reactive cross-linkers have limitations in uncovering the complete PPI map. In this study, a sulfoxide-containing MS-cleavable haloacetamide-based cross-linker, DBrASO, was designed and synthesized to complement lysine-reactive reagents and expand PPI coverage at a systems-level.

ANALYTICAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Crystal structures of OrfX1, OrfX2 and the OrfX1-OrfX3 complex from the orfX gene cluster of botulinum neurotoxin E1

Linfeng Gao, Kwok-ho Lam, Shun Liu, Adina Przykopanski, Johanna Luebke, Ruifeng Qi, Maren Krueger, Maria B. Nowakowska, Katja Selby, Francois P. Douillard, Martin B. Dorner, Kay Perry, Miia Lindstrom, Brigitte G. Dorner, Andreas Rummel, Rongsheng Jin

Summary: This article reports the crystal structures of OrfX1, OrfX2, and an OrfX1-OrfX3 complex encoded in the orfX cluster, which lays the foundation for future studies on the potential roles of OrfX proteins in oral intoxication and pathogenesis of BoNTs.

FEBS LETTERS (2023)

Article Multidisciplinary Sciences

Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants

Songhai Tian, Xiaozhe Xiong, Ji Zeng, Siyu Wang, Benjamin Jean-Marie Tremblay, Peng Chen, Baohua Chen, Min Liu, Pengsheng Chen, Kuanwei Sheng, Daniel Zeve, Wanshu Qi, David T. Breault, Cesar Rodriguez, Ralf Gerhard, Rongsheng Jin, Andrew C. Doxey, Min Dong

Summary: Toxin B (TcdB) is a major exotoxin responsible for diseases associated with Clostridioides difficile infection. This study identifies tissue factor pathway inhibitor (TFPI) as a host receptor for TcdB4 and TcdB10 subtypes, and reveals intragenic micro-recombination (IR)-driven changes on receptor specificity among TcdB variants.

NATURE COMMUNICATIONS (2022)

Article Immunology

Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies

Baohua Chen, Kay Perry, Rongsheng Jin

Summary: This study reports the identification of two critical epitopes on the virulence factor TcdA and sheds new insights into the neutralizing mechanisms of two potent camelid antibodies against TcdA. These findings provide potential targets for the development of epitope-focused vaccines against TcdA.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biophysics

An ensemble of cadherin-catenin-vinculin complex employs vinculin as the major F-actin binding mode

Bright Shi, Tsutomu Matsui, Shuo Qian, Thomas M. Weiss, Iain D. Nicholl, David J. E. Callaway, Zimei Bu

Summary: The cell-cell adhesion cadherin-catenin complexes recruit vinculin to the adherens junction (AJ), but the specific influence of vinculin on AJ structure and function remains unclear. This study identifies two patches of salt bridges that lock vinculin in an autoinhibited conformation and reconstitutes the vinculin activation mimetics bound to the cadherin-catenin complex. The dynamic cadherin-catenin-vinculin complex employs vinculin as the primary F-actin binding mode to strengthen AJ-cytoskeleton interactions.

BIOPHYSICAL JOURNAL (2023)

暂无数据